Forum of Clinical Oncology (Aug 2021)
Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental?
Abstract
The prevalence of diabetes mellitus is rapidly rising, especially in low- and middle-income countries. Also, early-onset diabetes is on the rise, and millions of individuals have to be on antidiabetic medications for a prolonged period. Therefore, more people are getting exposed to the adverse effects of antidiabetic medications.
Keywords